Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Genocea Biosciences, Inc. (GNCA) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Genocea Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1457612.
Total stock buying since 2014: $248,111,565.
Total stock sales since 2014: $9,807,530.
Total stock option exercises since 2014: $670,293.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2022 | 0 | $0 | 93,625,317 | $6,799,155 | 0 | $0 |
| 2021 | 0 | $0 | 0 | $0 | 36,498 | $79,930 |
| 2020 | 32,777,864 | $73,749,289 | 0 | $0 | 0 | $0 |
| 2019 | 142,716,663 | $168,041,938 | 0 | $0 | 36,873 | $19,911 |
| 2018 | 198,400 | $125,574 | 0 | $0 | 0 | $0 |
| 2017 | 53,332 | $322,172 | 51,213 | $310,446 | 98,332 | $263,970 |
| 2016 | 20,800 | $73,082 | 0 | $0 | 5,000 | $10,100 |
| 2015 | 703,800 | $5,799,510 | 108,503 | $1,368,733 | 40,787 | $88,247 |
| 2014 | 0 | $0 | 102,377 | $1,329,196 | 81,410 | $208,135 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2022-06 | 0 | $0 | 23,368 | $1,398 | 0 | $0 |
| 2022-05 | 0 | $0 | 93,571,025 | $6,762,523 | 0 | $0 |
| 2022-04 | 0 | $0 | 8,153 | $10,189 | 0 | $0 |
| 2022-03 | 0 | $0 | 22,771 | $25,045 | 0 | $0 |
| 2021-02 | 0 | $0 | 0 | $0 | 36,498 | $79,930 |
| 2020-11 | 4,760 | $9,805 | 0 | $0 | 0 | $0 |
| 2020-07 | 32,773,104 | $73,739,484 | 0 | $0 | 0 | $0 |
| 2019-06 | 33,285,704 | $116,499,964 | 0 | $0 | 0 | $0 |
| 2019-05 | 0 | $0 | 0 | $0 | 7,291 | $3,937 |
| 2019-04 | 0 | $0 | 0 | $0 | 7,291 | $3,937 |
| 2019-03 | 0 | $0 | 0 | $0 | 22,291 | $12,037 |
| 2019-02 | 109,430,959 | $51,541,974 | 0 | $0 | 0 | $0 |
| 2018-09 | 98,400 | $59,824 | 0 | $0 | 0 | $0 |
| 2018-08 | 75,000 | $45,750 | 0 | $0 | 0 | $0 |
| 2018-01 | 25,000 | $20,000 | 0 | $0 | 0 | $0 |
| 2017-07 | 0 | $0 | 45,000 | $270,000 | 45,000 | $139,050 |
| 2017-05 | 53,332 | $322,172 | 6,213 | $40,446 | 53,332 | $124,920 |
| 2016-11 | 16,800 | $57,562 | 0 | $0 | 5,000 | $10,100 |
| 2016-05 | 4,000 | $15,520 | 0 | $0 | 0 | $0 |
| 2015-12 | 3,800 | $24,510 | 0 | $0 | 13,906 | $28,090 |
| 2015-09 | 0 | $0 | 2,229 | $25,299 | 2,229 | $4,502 |
| 2015-08 | 0 | $0 | 2,229 | $29,088 | 7,229 | $14,602 |
| 2015-07 | 0 | $0 | 2,229 | $31,027 | 2,229 | $4,502 |
| 2015-06 | 0 | $0 | 88,851 | $1,161,841 | 2,229 | $4,502 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-02 | Duvall Diantha (CHIEF FINANCIAL OFFICER) | Sale | 2,710 | .06 | 162 |
| 2022-06-02 | Flechtner Jessica Baker (Chief Scientific Officer) | Sale | 3,156 | .06 | 188 |
| 2022-06-02 | Clark William D (President and CEO) | Sale | 8,046 | .06 | 482 |
| 2022-06-01 | Sumer Jacquelyn L (CHIEF LEGAL & COMPLIANCE OFF) | Sale | 2,500 | .06 | 150 |
| 2022-05-31 | Clark William D (President and CEO) | Sale | 117,244 | .06 | 7,269 |
| 2022-05-27 | Siber George | Sale | 20,425 | .07 | 1,327 |
| 2022-05-26 | Duvall Diantha (CHIEF FINANCIAL OFFICER) | Sale | 24,407 | .08 | 1,879 |
| 2022-05-25 | Chang Carmen (10% Owner) | Sale | 4,445,093 | .08 | 364,497 |
| 2022-05-25 | Nea 16 Gp, Llc (10% Owner) | Sale | 4,445,093 | .08 | 364,497 |
| 2022-05-25 | Makhzoumi Mohamad (10% Owner) | Sale | 4,445,093 | .08 | 364,497 |
| 2022-05-25 | Behbahani Ali (Director) | Sale | 4,445,093 | .08 | 364,497 |
| 2022-05-25 | Flechtner Jessica Baker (Chief Scientific Officer) | Sale | 16,525 | .09 | 1,454 |
| 2022-05-25 | Florence Anthony A. Jr. (10% Owner) | Sale | 4,445,093 | .08 | 364,497 |
| 2022-05-25 | Sonsini Peter W. (10% Owner) | Sale | 4,445,093 | .08 | 364,497 |
| 2022-05-25 | Walker Paul Edward (10% Owner) | Sale | 4,445,093 | .08 | 364,497 |
| 2022-05-25 | Baskett Forest (10% Owner) | Sale | 4,445,093 | .08 | 364,497 |
| 2022-05-25 | Sandell Scott D (10% Owner) | Sale | 4,445,093 | .08 | 364,497 |
| 2022-05-24 | Chang Carmen (10% Owner) | Sale | 5,931,843 | .07 | 385,569 |
| 2022-05-24 | Nea 16 Gp, Llc (10% Owner) | Sale | 5,931,843 | .07 | 385,569 |
| 2022-05-24 | Makhzoumi Mohamad (10% Owner) | Sale | 5,931,843 | .07 | 385,569 |
| 2022-05-24 | Behbahani Ali (Director) | Sale | 5,931,843 | .07 | 385,569 |
| 2022-05-24 | Florence Anthony A. Jr. (10% Owner) | Sale | 5,931,843 | .07 | 385,569 |
| 2022-05-24 | Sonsini Peter W. (10% Owner) | Sale | 5,931,843 | .07 | 385,569 |
| 2022-05-24 | Walker Paul Edward (10% Owner) | Sale | 5,931,843 | .07 | 385,569 |
| 2022-05-24 | Baskett Forest (10% Owner) | Sale | 5,931,843 | .07 | 385,569 |
| 2022-05-24 | Sandell Scott D (10% Owner) | Sale | 5,931,843 | .07 | 385,569 |
| 2022-04-04 | Aakalu Girish N (CHIEF BUSINESS OFFICER) | Sale | 963 | 1.25 | 1,203 |
| 2022-04-04 | Duvall Diantha (CHIEF FINANCIAL OFFICER) | Sale | 963 | 1.25 | 1,203 |
| 2022-04-04 | Flechtner Jessica Baker (Chief Scientific Officer) | Sale | 1,212 | 1.25 | 1,515 |
| 2022-04-04 | Clark William D (President and CEO) | Sale | 3,924 | 1.25 | 4,905 |
| 2022-04-04 | Davis Thomas Andrew (CHIEF MEDICAL OFFICER) | Sale | 1,091 | 1.25 | 1,363 |
| 2022-03-16 | Aakalu Girish N (CHIEF BUSINESS OFFICER) | Sale | 2,397 | 1.10 | 2,636 |
| 2022-03-16 | Duvall Diantha (CHIEF FINANCIAL OFFICER) | Sale | 2,873 | 1.10 | 3,160 |
| 2022-03-16 | Flechtner Jessica Baker (Chief Scientific Officer) | Sale | 3,349 | 1.10 | 3,683 |
| 2022-03-16 | Clark William D (President and CEO) | Sale | 11,435 | 1.10 | 12,578 |
| 2022-03-16 | Davis Thomas Andrew (CHIEF MEDICAL OFFICER) | Sale | 2,717 | 1.10 | 2,988 |
| 2021-02-17 | Clark William D (President and CEO) | Option Ex | 36,498 | 2.19 | 79,930 |
| 2020-11-10 | Clark William D (President and CEO) | Buy | 4,760 | 2.06 | 9,805 |
| 2020-07-24 | Chang Carmen (10% Owner) | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2020-07-24 | Nea 16 Gp, Llc (10% Owner) | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2020-07-24 | Makhzoumi Mohamad (10% Owner) | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2020-07-24 | Behbahani Ali (Director) | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2020-07-24 | Florence Anthony A. Jr. (10% Owner) | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2020-07-24 | Sonsini Peter W. (10% Owner) | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2020-07-24 | Walker Paul Edward (10% Owner) | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2020-07-24 | Baskett Forest (10% Owner) | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2020-07-24 | Sandell Scott D (10% Owner) | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2020-07-24 | Makower Joshua (10% Owner) | Buy | 3,151,260 | 2.25 | 7,090,335 |
| 2020-07-24 | Glaxosmithkline Plc | Buy | 1,260,504 | 2.25 | 2,836,134 |
| 2019-06-24 | Chang Carmen (10% Owner) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-06-24 | Nea 16 Gp, Llc (10% Owner) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-06-24 | Makhzoumi Mohamad (10% Owner) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-06-24 | Behbahani Ali (Director) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-06-24 | Florence Anthony A. Jr. (10% Owner) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-06-24 | Sonsini Peter W. (10% Owner) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-06-24 | Baskett Forest (10% Owner) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-06-24 | Sandell Scott D (10% Owner) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-06-24 | Makower Joshua (10% Owner) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-06-24 | Mott David M (10% Owner) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-06-24 | Glaxosmithkline Plc | Buy | 1,857,142 | 3.50 | 6,499,997 |
| 2019-06-24 | Barris Peter J (10% Owner) | Buy | 2,857,142 | 3.50 | 9,999,997 |
| 2019-05-08 | Singh Narinderjeet (SENIOR VP, PS&M) | Option Ex | 7,291 | .54 | 3,937 |
| 2019-04-11 | Singh Narinderjeet (SENIOR VP, PS&M) | Option Ex | 7,291 | .54 | 3,937 |
| 2019-03-18 | Singh Narinderjeet (SENIOR VP, PS&M) | Option Ex | 7,291 | .54 | 3,937 |
| 2019-03-15 | Clark William D (President and CEO) | Option Ex | 15,000 | .54 | 8,100 |
| 2019-02-14 | Chang Carmen (10% Owner) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2019-02-14 | Nea 16 Gp, Llc (10% Owner) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2019-02-14 | Makhzoumi Mohamad (10% Owner) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2019-02-14 | Behbahani Ali (Director) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2019-02-14 | Florence Anthony A. Jr. (10% Owner) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2019-02-14 | Sonsini Peter W. (10% Owner) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2019-02-14 | Baskett Forest (10% Owner) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2019-02-14 | Sandell Scott D (10% Owner) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2019-02-14 | Makower Joshua (10% Owner) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2019-02-14 | Mott David M (10% Owner) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2019-02-14 | Barris Peter J (10% Owner) | Buy | 9,948,269 | .47 | 4,685,634 |
| 2018-09-13 | Alfieri Michael (Principle Financial Officer) | Buy | 10,000 | .54 | 5,400 |
| 2018-09-07 | Siber George | Buy | 13,400 | .61 | 8,174 |
| 2018-09-06 | Siber George | Buy | 25,000 | .61 | 15,250 |
| 2018-09-05 | Siber George | Buy | 25,000 | .62 | 15,500 |
| 2018-09-04 | Siber George | Buy | 25,000 | .62 | 15,500 |
| 2018-08-31 | Siber George | Buy | 25,000 | .61 | 15,250 |
| 2018-08-30 | Siber George | Buy | 25,000 | .61 | 15,250 |
| 2018-08-29 | Siber George | Buy | 25,000 | .61 | 15,250 |
| 2018-01-17 | Clark William D (President and CEO) | Buy | 25,000 | .80 | 20,000 |
| 2017-07-24 | Poole Jonathan (Chief Financial Officer) | Sale | 45,000 | 6.00 | 270,000 |
| 2017-07-24 | Poole Jonathan (Chief Financial Officer) | Option Ex | 45,000 | 3.09 | 139,050 |
| 2017-05-19 | Siber George | Buy | 22,287 | 6.07 | 135,282 |
| 2017-05-19 | Siber George | Option Ex | 22,287 | 2.62 | 58,391 |
| 2017-05-18 | Siber George | Buy | 31,045 | 6.02 | 186,890 |
| 2017-05-18 | Siber George | Option Ex | 31,045 | 2.14 | 66,529 |
| 2017-05-08 | Poole Jonathan (Chief Financial Officer) | Sale | 6,213 | 6.51 | 40,446 |
| 2016-11-09 | Hetherington Seth V (Chief Medical Officer) | Option Ex | 5,000 | 2.02 | 10,100 |
| 2016-11-08 | Hoffman Eric S (Chief Business Officer) | Buy | 3,000 | 3.59 | 10,770 |
| 2016-11-07 | Hoffman Eric S (Chief Business Officer) | Buy | 4,000 | 3.41 | 13,640 |
| 2016-11-07 | Poole Jonathan (Chief Financial Officer) | Buy | 7,000 | 3.34 | 23,380 |
| 2016-11-07 | Clark William D (President and CEO) | Buy | 2,800 | 3.49 | 9,772 |
| 2016-05-09 | Poole Jonathan (Chief Financial Officer) | Buy | 4,000 | 3.88 | 15,520 |
| 2015-12-16 | Clark William D (President and CEO) | Buy | 3,800 | 6.45 | 24,510 |
| 2015-12-14 | Flechtner Jessica Baker (VP of Research) | Option Ex | 8,906 | 2.02 | 17,990 |
| 2015-12-11 | Hetherington Seth V (Chief Medical Officer) | Option Ex | 5,000 | 2.02 | 10,100 |
| 2015-09-01 | Flechtner Jessica Baker (Sr. VP of Research) | Sale | 2,229 | 11.35 | 25,299 |
| 2015-09-01 | Flechtner Jessica Baker (Sr. VP of Research) | Option Ex | 2,229 | 2.02 | 4,502 |
| 2015-08-07 | Hetherington Seth V (Chief Medical Officer) | Option Ex | 5,000 | 2.02 | 10,100 |
| 2015-08-03 | Flechtner Jessica Baker (Sr. VP of Research) | Sale | 2,229 | 13.05 | 29,088 |
| 2015-08-03 | Flechtner Jessica Baker (Sr. VP of Research) | Option Ex | 2,229 | 2.02 | 4,502 |
| 2015-07-01 | Flechtner Jessica Baker (Sr. VP of Research) | Sale | 2,229 | 13.92 | 31,027 |
| 2015-07-01 | Flechtner Jessica Baker (Sr. VP of Research) | Option Ex | 2,229 | 2.02 | 4,502 |
| 2015-06-19 | Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) | Sale | 1,000 | 13.00 | 13,000 |
| 2015-06-18 | Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) | Sale | 29,004 | 13.04 | 378,212 |
| 2015-06-17 | Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) | Sale | 10,618 | 13.01 | 138,140 |
| 2015-06-16 | Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) | Sale | 46,000 | 13.24 | 609,040 |
| 2015-06-01 | Flechtner Jessica Baker (Sr. VP of Research) | Sale | 2,229 | 10.52 | 23,449 |
| 2015-06-01 | Flechtner Jessica Baker (Sr. VP of Research) | Option Ex | 2,229 | 2.02 | 4,502 |
| 2015-05-01 | Flechtner Jessica Baker (Sr. VP of Research) | Sale | 2,229 | 10.21 | 22,758 |
| 2015-05-01 | Flechtner Jessica Baker (Sr. VP of Research) | Option Ex | 2,229 | 2.02 | 4,502 |
| 2015-04-01 | Flechtner Jessica Baker (Sr. VP of Research) | Sale | 2,283 | 11.77 | 26,870 |
| 2015-04-01 | Flechtner Jessica Baker (Sr. VP of Research) | Option Ex | 2,283 | 2.86 | 6,529 |
| 2015-03-17 | Hoffman Stephen J (Director) | Buy | 700,000 | 8.25 | 5,775,000 |
| 2015-03-02 | Flechtner Jessica Baker (Sr. VP of Research) | Sale | 3,754 | 8.50 | 31,909 |
| 2015-03-02 | Flechtner Jessica Baker (Sr. VP of Research) | Option Ex | 3,754 | 2.62 | 9,835 |
| 2015-02-02 | Flechtner Jessica Baker (Sr. VP of Research) | Sale | 3,085 | 8.50 | 26,222 |
| 2015-02-02 | Flechtner Jessica Baker (Sr. VP of Research) | Option Ex | 3,085 | 2.38 | 7,342 |
| 2015-01-29 | Flechtner Jessica Baker (Sr. VP of Research) | Sale | 1,614 | 8.50 | 13,719 |
| 2015-01-29 | Flechtner Jessica Baker (Sr. VP of Research) | Option Ex | 1,614 | 2.38 | 3,841 |
| 2014-12-12 | Clark William D (President and CEO) | Option Ex | 19,807 | 2.86 | 56,648 |
| 2014-09-12 | Flechtner Jessica Baker (VP of Research) | Sale | 1,932 | 12.00 | 23,184 |
| 2014-09-12 | Flechtner Jessica Baker (VP of Research) | Option Ex | 3,612 | 2.02 | 7,314 |
| 2014-09-11 | Giannasca Paul (VP of Development) | Sale | 4,071 | 11.84 | 48,200 |
| 2014-09-11 | Giannasca Paul (VP of Development) | Option Ex | 4,071 | 2.02 | 8,223 |
| 2014-09-11 | Flechtner Jessica Baker (VP of Research) | Sale | 4,503 | 12.00 | 54,036 |
| 2014-09-11 | Flechtner Jessica Baker (VP of Research) | Option Ex | 4,503 | 2.02 | 9,118 |
| 2014-09-10 | Giannasca Paul (VP of Development) | Sale | 834 | 12.35 | 10,299 |
| 2014-09-10 | Giannasca Paul (VP of Development) | Option Ex | 834 | 2.02 | 1,684 |
| 2014-09-09 | Giannasca Paul (VP of Development) | Sale | 2,455 | 12.43 | 30,515 |
| 2014-09-09 | Giannasca Paul (VP of Development) | Option Ex | 2,455 | 2.02 | 4,959 |
| 2014-09-08 | Giannasca Paul (VP of Development) | Sale | 2,970 | 12.80 | 38,016 |
| 2014-09-08 | Giannasca Paul (VP of Development) | Option Ex | 2,970 | 2.02 | 5,999 |
| 2014-09-02 | Giannasca Paul (VP of Development) | Sale | 5,398 | 12.51 | 67,528 |
| 2014-09-02 | Giannasca Paul (VP of Development) | Option Ex | 5,398 | 2.86 | 15,438 |
| 2014-09-02 | Clark William D (President and CEO) | Option Ex | 20,000 | 2.86 | 57,200 |
| 2014-08-29 | Giannasca Paul (VP of Development) | Sale | 855 | 12.86 | 10,995 |
| 2014-08-29 | Giannasca Paul (VP of Development) | Option Ex | 855 | 2.86 | 2,445 |
| 2014-08-28 | Giannasca Paul (VP of Development) | Sale | 4,602 | 12.36 | 56,880 |
| 2014-08-28 | Giannasca Paul (VP of Development) | Option Ex | 4,602 | 2.86 | 13,161 |
| 2014-08-27 | Giannasca Paul (VP of Development) | Sale | 1,303 | 12.77 | 16,639 |
| 2014-08-27 | Giannasca Paul (VP of Development) | Option Ex | 1,303 | 2.86 | 3,726 |
| 2014-08-18 | Hetherington Seth V (Chief Medical Officer) | Option Ex | 11,000 | 2.02 | 22,220 |
| 2014-08-14 | Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) | Sale | 6,755 | 13.01 | 87,882 |
| 2014-08-13 | Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) | Sale | 2,905 | 13.00 | 37,765 |
| 2014-08-12 | Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) | Sale | 20,990 | 13.03 | 273,499 |
| 2014-08-11 | Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) | Sale | 1,428 | 13.24 | 18,906 |
| 2014-08-08 | Polaris Venture Partners Special Founders' Fund V, L.p. (10% Owner) | Sale | 41,376 | 13.41 | 554,852 |
Insider trading activities including stock purchases, stock sales, and option exercises of GNCA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Genocea Biosciences, Inc. (symbol GNCA, CIK number 1457612) see the Securities and Exchange Commission (SEC) website.